Method and composition for regulating and controlling autoimmune diseases through polyamine compound

A technology of polyamine compounds and compositions, applied in the fields of biology and medicine, can solve problems such as bone marrow suppression and side effects

Active Publication Date: 2018-01-16
SHANGHAI INST OF BIOLOGICAL SCI CHINESE ACAD OF SCI
View PDF1 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Currently, mitoxantrone is used for the treatment of progressive or worsening MS, but long-term use causes severe myelosuppression, gastrointestinal bleeding, mucositis and gastritis
And various other immunosuppressants such as cyclophosphamide, methotrexate, statins, etc. also have certain side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method and composition for regulating and controlling autoimmune diseases through polyamine compound
  • Method and composition for regulating and controlling autoimmune diseases through polyamine compound
  • Method and composition for regulating and controlling autoimmune diseases through polyamine compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0100] Establishment of EAE animal model:

[0101] Establishment and administration of EAE model: On the day of immunization (Day 0), each mouse was given 200 μl of emulsified antigen on the back for subcutaneous injection at two points, 100 μl on each side, and each mouse was given 200 μl of PT, and injected into the tail vein. On the second day of immunization, each mouse was given 200 μl of PT again and injected into the tail vein. Prevention and treatment: On the day of immunization, each mouse in the treatment group was given 50 mg / kg of spermidine intraperitoneally, and continued administration and observation; Disease treatment: EAE mice began to develop symptoms, that is, on the 11th day, when the tail of the mice began to appear weak and drooping For administration, mice in the treatment group were given 50 mg / kg of spermidine intraperitoneally, and the administration was continued to observe the experiment; mice in the control group were injected with corresponding P...

Embodiment 2

[0104] Macrophage adoptive transfer EAE model experiment:

[0105] ①Establishment of macrophage adoptive transfer model

[0106] Firstly, the EAE model was induced in the donor wild-type C57BL / 6 mice, and spermidine treatment was given when the disease began to show symptoms (12th day). After the 17th day of immunization, the spleen cells of the two groups of EAE mice were taken out and treated with CD11b CD11b+ macrophages were sorted out by microbeads (Miltenyl Biotech). The macrophages selected from the two groups were divided into 1x10 7 The concentration of cells / ml and the PBS control were injected into the same batch of induced wild-type EAE mice from the tail vein (at this time, the recipient EAE mice were on the 10th day after immunization), and then the three groups of recipients were observed every day. The disease occurrence and development of the mice were scored.

[0107] ②Establishment of the molecular mechanism of adoptive transfer of macrophages

[0108] The...

Embodiment 3

[0110] Adoptive transfer of T cells to establish EAE model:

[0111] The EAE model can be successfully modeled not only by direct immunization with antigens, but also by adoptive transfer of pathogenic T cells. Here, we first induced the EAE model in donor wild-type C57BL / 6 mice. After 10 days, we isolated the spleen cells of EAE mice and stimulated them with 20 μg / ml MOG 35-55 in vitro for three days. , another group was treated with 20 μg / ml MOG 35-55 plus 10 μM spermidine for three days. After 72 hours, CD4+ T cells were isolated and administered to recipient mice 3×10 6 cells / only, and the recipient mice were irradiated with a semi-lethal dose of 400cGy. Each mouse was treated with 200 μl PT on day 0 and day 2 of T cell adoptive transfer to ensure opening of the blood-brain barrier. Then, the occurrence and development of the disease in the recipient mice were observed every day and scored.

[0112] In addition, spleen cells can be isolated from actively immunized EAE ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a method and composition for regulating and controlling autoimmune diseases through a polyamine compound. The invention provides macrophages treated by a polyamine compound, a corresponding cellular preparation and a composition for up-regulation of an internal arginase level or down-regulation of an internal arginase level. The preparation and composition can be used for treating multiple sclerosis, significantly reduces inflammatory cell infiltration, inhibits inflammatory response through down-regulation of a proinflammatory cytokine level, reduces inflammatory cell infiltration and a demyelination degree of the central nervous system and reduces the incidence of multiple sclerosis and pathogenetic conditions.

Description

technical field [0001] The present invention relates to the fields of biology and medicine, more specifically, the present invention relates to a method and composition for regulating autoimmunity by polyamine compounds. Background technique [0002] Multiple sclerosis (MS) is a typical autoimmune disease characterized by white matter demyelination of the central nervous system (central nervous system, CNS). Inflammatory damage to the sheath and axon is mainly due to the blockage of nerve signal transmission caused by inflammation, demyelination, and hypergliosis caused by immune cells crossing the blood-brain barrier. The lesions were multifocal, involving white matter, optic nerves, spinal cord conduction tracts, brainstem, and cerebellum. Patients are often accompanied by fatigue, limb weakness, spasticity, sensory disturbance, pain, cerebellar ataxia, tremor, visual impairment, ophthalmoplegia, autonomic dysfunction and psychological disturbance, covering the central ne...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/15A61K45/06A61K31/132A61K38/50A61P25/28A61P37/02A61P43/00
Inventor 时玉舫王莹杨茜曹巍
Owner SHANGHAI INST OF BIOLOGICAL SCI CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap